NCT00765479View on ClinicalTrials.gov

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

July 31, 2013

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

soy protein isolate

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

60612-7243

University of Illinois Cancer Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Illinois at Chicago

OTHER

NCT00765479 - Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter